Concepedia

Cheryl L. Thomas

CL

Statistics

Publications

20

Citations

1.3K

H-Index

17

Active since

1988

Affiliations

Frederick National Laboratory for Cancer Research(Current)

Target (United States)

National Cancer Institute

Center for Cancer Research

Science Applications International Corporation (United States)

Cheryl L. Thomas is an author at Frederick National Laboratory for Cancer Research specializing in life sciences, molecular biology, and cell signaling.

Publications per year

1988–2020

20

Publications

20

Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs

Ancy D. Nalli, Lauren E. Brown, Cheryl L. Thomas et al. · Scientific Reports · 2018 · 297 citations · Full text

, , +17

Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.

G D Blickenstaff, Mark Sklar, Cheryl L. Thomas et al. · Journal of Biological Chemistry · 1988 · 190 citations · Full text

, , +12

Developmental Expression of the Tissue Insulin-like Growth Factor II/Mannose 6-Phosphate Receptor in the Rat

Mark Sklar, Cheryl L. Thomas, S. Peter Nissley · Journal of Biological Chemistry · 1989 · 103 citations · Full text

, , +15

Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of β-galactosidase and the binding of β-galactosidase to purified IGF-II/mannose 6-phosphate receptor

Cheryl L. Thomas, Lawrence A. Greenstein, L Lee et al. · Journal of Biological Chemistry · 1989 · 94 citations · Full text

, , +15

Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation

Curtis J. Henrich, Alan D. Brooks, Karen L. Erickson et al. · Cell Death and Disease · 2015 · 60 citations · Full text

, , +17

1–5 of 20